Cargando…

Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer

Most deaths from carcinomas are caused by the hematogenous dissemination of cancer cells to distant organs and the eventual development of metastases. When found in the bone marrow or peripheral blood of carcinoma patients, occult cancer cells are referred to as disseminated tumor cells (DTCs) or ci...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Ignatiadis, Michail (Editor ), Sotiriou, Christos (Editor ), Pantel, Klaus (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2012.
Edición:1st ed. 2012.
Colección:Recent Results in Cancer Research, 195
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-642-28160-0
003 DE-He213
005 20230810210219.0
007 cr nn 008mamaa
008 120420s2012 gw | s |||| 0|eng d
020 |a 9783642281600  |9 978-3-642-28160-0 
024 7 |a 10.1007/978-3-642-28160-0  |2 doi 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer  |h [electronic resource] /  |c edited by Michail Ignatiadis, Christos Sotiriou, Klaus Pantel. 
250 |a 1st ed. 2012. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2012. 
300 |a XIV, 254 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Recent Results in Cancer Research,  |x 2197-6767 ;  |v 195 
520 |a Most deaths from carcinomas are caused by the hematogenous dissemination of cancer cells to distant organs and the eventual development of metastases. When found in the bone marrow or peripheral blood of carcinoma patients, occult cancer cells are referred to as disseminated tumor cells (DTCs) or circulating tumor cells (CTCs). CTCs and DTCs are considered surrogates of minimal residual disease, i.e., the presence of malignant cells in distant organs that are undetectable by conventional imaging and laboratory tests used for tumor staging after curative surgery of the primary tumor.   In this book, leading investigators in the field provide up-to-date information on a series of important questions, including:   -  How can the study of minimal residual disease and CTCs help us to better understand breast cancer metastasis? -  What technologies are available for the detection and characterization of CTCs and DTCs, and what are their relative merits? -  How are DTCs and CTCs relevant to clinical research and practice? - What is the role of other blood-based biomarkers such as circulating endothelial cells and circulating nucleic acids? -  What are the challenges in drug and biomarker co-development and the use of CTCs for companion diagnostic development?   This book will be of interest and assistance to all who are engaged in the modern management of breast cancer. 
650 0 |a Oncology. 
650 0 |a Gynecology . 
650 0 |a Cancer  |x Treatment. 
650 0 |a Pathology. 
650 0 |a Cancer. 
650 1 4 |a Oncology. 
650 2 4 |a Gynecology. 
650 2 4 |a Cancer Therapy. 
650 2 4 |a Pathology. 
650 2 4 |a Cancer Biology. 
700 1 |a Ignatiadis, Michail.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Sotiriou, Christos.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Pantel, Klaus.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783642445873 
776 0 8 |i Printed edition:  |z 9783642281617 
776 0 8 |i Printed edition:  |z 9783642281594 
830 0 |a Recent Results in Cancer Research,  |x 2197-6767 ;  |v 195 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-642-28160-0  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)